WO2026027806 - ULVA AUSTRALIS EXTRACT WITH ANTIOXIDANT ACTIVITY AND CELL PROLIFERATION ACTIVITY
National phase entry is expected:
Publication Number
WO/2026/027806
Publication Date
05.02.2026
International Application No.
PCT/ES2025/070455
International Filing Date
23.07.2025
Title **
[English]
ULVA AUSTRALIS EXTRACT WITH ANTIOXIDANT ACTIVITY AND CELL PROLIFERATION ACTIVITY
[Spanish]
EXTRACTO DE ULVA AUSTRALIS CON ACTIVIDAD ANTIOXIDANTE Y ACTIVIDAD PROLIFERATIVA CELULAR
[French]
EXTRAIT D'ULVA AUSTRALIS À ACTIVITÉ ANTIOXYDANTE ET ACTIVITÉ PROLIFÉRATIVE CELLULAIRE
Applicants **
UNIVERSIDAD DE ALICANTE
Inventors
VALVERDE URREA, Miguel Rodrigo
LÓPEZ MOYA, Federico
TERRADAS FERNÁNDEZ, Marc
LÓPEZ LLORCA, Luis Vicente
Priority Data
P202430643
29.07.2024
ES
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
SPTO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2070 | |
| EPO | Filing, Examination, Granting | 9213 | |
| Japan | Filing, Examination, Granting | 2141 | |
| South Korea | Filing, Examination, Granting | 2056 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
20,220
Contact Us
Abstract[English]
The present invention relates to an ulva australis extract with antioxidant activity and cell proliferation activity for use as a drug to prevent and/or treat neurodegenerative diseases of the retina, especially those associated with oxidative stress or loss of photoreceptors, such as age-related macular degeneration, glaucoma, inherited retinal dystrophies, diabetic retinopathy and retinitis pigmentosa.[Spanish]
Extracto de Ulva australis con actividad antioxidante y actividad proliferativa celular para su uso como medicamento para la prevención y/ o el tratamiento de enfermedades neurodegenerativas de la retina, especialmente aquellas que cursan con estrés oxidativo o con la pérdida de fotorreceptores, como la degeneración macular asociada a la edad, glaucoma, distrofias hereditarias de retina, retinopatía diabética y la retinosis pigmentaria.[French]
L'invention concerne un extrait d'Ulva australis à activité antioxydante et activité proliférative cellulaire destiné à être utilisé comme médicament pour la prévention et/ou le traitement de maladies neurodégénératives de la rétine, notamment celles qui s'accompagnent de stress oxydatif ou de la perte de photorécepteurs, comme la dégénérescence maculaire associée à l'âge, le glaucome, les dystrophies héréditaires de la rétine, la rétinopathie diabétique et la rétinite pigmentaire.